|
1
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Slack FJ and Weidhaas JB: MicroRNA in
cancer prognosis. N Engl J Med. 359:2720–2722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng CJ and Slack FJ: The duality of
oncomiR addiction in the maintenance and treatment of cancer.
Cancer J. 18:232–237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li L, Zhou L, Li Y, Lin S and Tomuleasa C:
MicroRNA-21 stimulates gastric cancer growth and invasion by
inhibiting the tumor suppressor effects of programmed cell death
protein 4 and phosphatase and tensin homolog. J BUON. 19:228–236.
2014.PubMed/NCBI
|
|
5
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: MicroRNA-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park SY, Kim H, Yoon S, Bae JA, Choi SY,
Jung YD and Kim KK: KITENIN-targeting microRNA-124 suppresses
colorectal cancer cell motility and tumorigenesis. Mol Ther.
22:1653–1664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang S, Zhao Y, Hu K, Xu C, Wang L, Liu J,
Yao A, Zhang H and Cao F: miR-124 exhibits antiproliferative and
antiaggressive effects on prostate cancer cells through PACE4
pathway. Prostate. 74:1095–1106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Wang Q, Zhao Q and Di W: miR-124
inhibits the migration and invasion of ovarian cancer cells by
targeting SphK1. J Ovarian Res. 6:842013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR 200b and miR 200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu A, Yu Q, Peng Z, Huang Y, Diao S,
Cheng J, Wang W and Hong M: miR-200b inhibits CD133+
glioma cells by targeting the AKT pathway. Oncol Lett.
13:4701–4707. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng M, Tang HL, Lu XH, Liu MY, Lu XM, Gu
YX, Liu JF and He ZM: miR-26a suppresses tumor growth and
metastasis by targeting FGF9 in gastric cancer. PLoS One.
8:e726622013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jennings RT and Knaus UG: Rho family and
Rap GTPase activation assays. Methods Mol Biol. 1124:79–88. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao H, Dong T, Zhou H, Wang L, Huang A,
Feng B, Quan Y, Jin R, Zhang W, Sun J, et al: miR-320a suppresses
colorectal cancer progression by targeting Rac1. Carcinogenesis.
35:886–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dokmanovic M, Hirsch DS, Shen Y and Wu WJ:
Rac1 contributes to trastuzumab resistance of breast cancer cells:
Rac1 as a potential therapeutic target for the treatment of
trastuzumab-resistant breast cancer. Mol Cancer Ther. 8:1557–1569.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhan H, Liang H, Liu X, Deng J, Wang B and
Hao X: Expression of Rac1, HIF-1α, and VEGF in gastric carcinoma:
Correlation with angiogenesis and prognosis. Onkologie. 36:102–107.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen B, Gao Y, Jiang T, Ding J, Zeng Y, Xu
R and Jiang X: Inhibition of tumor cell migration and invasion
through knockdown of Rac1 expression in medulloblastoma cells. Cell
Mol Neurobiol. 31:251–257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gastonguay A, Berg T, Hauser AD, Schuld N,
Lorimer E and Williams CL: The role of Rac1 in the regulation of
NF-κB activity, cell proliferation, and cell migration in non-small
cell lung carcinoma. Cancer Biol Ther. 13:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshida T, Zhang Y, Rivera Rosado LA, Chen
J, Khan T, Moon SY and Zhang B: Blockade of Rac1 activity induces
G1 cell cycle arrest or apoptosis in breast cancer cells through
downregulation of cyclin D1, survivin, and X-linked inhibitor of
apoptosis protein. Mol Cancer Ther. 9:1657–1668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rathinam R, Berrier A and Alahari SK: Role
of Rho GTPases and their regulators in cancer progression. Front
Biosci. 16:2561–2571. 2011. View
Article : Google Scholar
|
|
27
|
Bid HK, Roberts RD, Manchanda PK and
Houghton PJ: RAC1: An emerging therapeutic option for targeting
cancer angiogenesis and metastasis. Mol Cancer Ther. 12:1925–1934.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vader P, van der Meel R, Symons MH, Fens
MH, Pieters E, Wilschut KJ, Storm G, Jarzabek M, Gallagher WM,
Schiffelers RM, et al: Examining the role of Rac1 in tumor
angiogenesis and growth: A clinically relevant RNAi-mediated
approach. Angiogenesis. 14:457–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Li S, Yan Q, Chen X, Yang Y, Liu
X and Wan X: Interferon-β induced microRNA-129-5p down-regulates
HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical
cancer cells. PLoS One. 8:e813662013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang WB, Chen PH, Hsu T, Fu TF, Su WC,
Liaw H, Chang WC and Hung JJ: Sp1-mediated microRNA-182 expression
regulates lung cancer progression. Oncotarget. 5:740–753. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: miR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim DW, Ko SM, Jeon YJ, Noh YW, Choi NJ,
Cho SD, Moon HS, Cho YS, Shin JC, Park SM, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao Y, Zhang W, Guo Z, Ma F, Wu Y, Bai Y,
Gong W, Chen Y, Cheng T, Zhi F, et al: Inhibition of the
transcription factor Sp1 suppresses colon cancer stem cell growth
and induces apoptosis in vitro and in nude mouse xenografts.
Oncol Rep. 30:1782–1792. 2013. View Article : Google Scholar : PubMed/NCBI
|
